Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
FEMALE
NCT06780813

Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients

Led by National and Kapodistrian University of Athens · Updated on 2025-01-17

400

Participants Needed

1

Research Sites

68 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The incidence of surgical-site infection (SSI) and complications related to wound healing reaches 10-20% of gynecological cancer patients. Each complication may dramatically prolong the hospitalization period and increase the economic burden of hospital care. Appropriate wound care and tissue oxygenation are of special importance for wound healing. Assuming adequate perfusion, the easiest, safest, and most effective way to improve tissue oxygenation is to increase the fraction of inspired oxygen. However, there is considerable controversy as to whether supplemental oxygen actually reduces SSI and healing-related complications as to date, there is absence of relevant data.

CONDITIONS

Official Title

Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients

Who Can Participate

Age: 18Years - 85Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Obese (BMI >30 kg/m2) women with gynecological cancer
  • Optimized preoperative blood counts: hemoglobin >11 g/dl, white blood cells between 4000-11000 X 10^9/L, platelets between 150,000-400,000 X 10^9/L
  • If receiving neoadjuvant therapy, at least 3 weeks have passed since the last treatment cycle before surgery
Not Eligible

You will not qualify if you...

  • Active immunosuppression
  • Existing infection of the abdominal wall
  • Current sepsis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

First department of Obstetrics and Gynecology

Athens, Greece, 11528

Actively Recruiting

Loading map...

Research Team

V

Vasilios Pergialiotis, Assistant Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here